Matt TurnerPatient Affordability
Frank BurrellScientific Storytelling
David LinetskyPoint-of-Care Marketing
Stacey GandlerBrand Nourishment
Matthew DurhamOmnidynamic Marketing
Suma Ramadas, PhDMedical Affairs
Brenda SnowAuthentic Patient Voice
Amy GilesIncreasing Engagement
Paul TheisenPatient Acquisition
Liz KaneImpactful Strategy
Daniel SontupeMarket Access
Bud BilanichSuccess Coach
Pat PurcellMeeting Engagement
Joey CohenMedication Adherence
Tasigna is the first and only second-generation tyrosine kinase inhibitor approved in the EU ...
San Antonio, Texas, Jan. 29, 2018 (GLOBE NEWSWIRE) -- South Texas Blood & Tissue ...
Username
Email
Password
Confirm Password
Remember Me
Username or Email